Bioxcel Therapeutics Inc.
BTAIQDrug Manufacturers - Specialty & Generic
$0.01−13.00%As of Oct 29vs prior close
- Market cap
- $407K
- P/E (TTM)
- –
- P/E (FY1)
- -0.0×
- From 52W high
- −99.40%
- EPS (LTM)
- -$2.81
- Revenue (LTM)
- $742K
- Net margin
- -9549.87%
- Dividend yield
- 0.00%
Nomior Score
0
Fragile PremiumBottom 1% of the scored universe
Growth—
Quality6
Value33
Momentum12
Resilience7
Growth
+19.63%revenue a year over 3 fiscal years
YE22 $375KLTM $742K
Connections
Revenue to profitQ2 YE26
The operating loss was 5601% of revenue, narrower by 7609 pts on a year.
Who owns it
1fund, 1 tracked portfolio